-
Posted by
Two Blokes April 23, 2025 -
Filed in
Stock
-
18 views
Benitec Biopharma (BNTC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
